The post White Sox Give Robert $5 Million Raise After Third 100-Loss Season appeared on BitcoinEthereumNews.com. ATLANTA, GEORGIA – AUGUST 20: Luis Robert Jr. #88 of the Chicago White Sox looks on during the sixth inning against the Atlanta Braves at Truist Park on August 20, 2025 in Atlanta, Georgia. (Photo by Todd Kirkland/Getty Images) Getty Images Talk about playing the long game. The White Sox refuse to give on Luis Robert Jr., both as their center fielder and a potentially valuable asset. They surprisingly exercised a $20 million option on his contract for 2026 even though he has played only slightly above replacement level since 2023. Health has also been a major issue, with Robert playing 100 games in ’24 and 110 in ’25, when a mid-season resurgence was cut short by a season-ending hamstring strain in late August. Robert, Andrew Benintendi and Korey Lee are the only members of the 40-man roster left from the start of the 121-loss ordeal two seasons ago. Their high salaries and inconsistent performance have limited their appeal in trades. Benintendi, who is heading into the fourth season of a five-year, $75 million deal, has raised his production over the last year and a half, delivering an .830 OPS in the second half of ’24 before a second consecutive 20-homer season in ’25. The Sox would surely trade Benintendi this winter but it hasn’t made sense to cut ties at any point, as the remaining $31 million on his contract is guaranteed. But Robert presents a different situation entirely for a team that has lost 100-plus games three years in a row. General Manager Chris Getz could have taken the easy way out — some would say the logical way out — by declining the first of Robert’s two $20 million options in the six-year, $50 million salary he was given as an electrifying speed-power-defense prospect in 2020. The… The post White Sox Give Robert $5 Million Raise After Third 100-Loss Season appeared on BitcoinEthereumNews.com. ATLANTA, GEORGIA – AUGUST 20: Luis Robert Jr. #88 of the Chicago White Sox looks on during the sixth inning against the Atlanta Braves at Truist Park on August 20, 2025 in Atlanta, Georgia. (Photo by Todd Kirkland/Getty Images) Getty Images Talk about playing the long game. The White Sox refuse to give on Luis Robert Jr., both as their center fielder and a potentially valuable asset. They surprisingly exercised a $20 million option on his contract for 2026 even though he has played only slightly above replacement level since 2023. Health has also been a major issue, with Robert playing 100 games in ’24 and 110 in ’25, when a mid-season resurgence was cut short by a season-ending hamstring strain in late August. Robert, Andrew Benintendi and Korey Lee are the only members of the 40-man roster left from the start of the 121-loss ordeal two seasons ago. Their high salaries and inconsistent performance have limited their appeal in trades. Benintendi, who is heading into the fourth season of a five-year, $75 million deal, has raised his production over the last year and a half, delivering an .830 OPS in the second half of ’24 before a second consecutive 20-homer season in ’25. The Sox would surely trade Benintendi this winter but it hasn’t made sense to cut ties at any point, as the remaining $31 million on his contract is guaranteed. But Robert presents a different situation entirely for a team that has lost 100-plus games three years in a row. General Manager Chris Getz could have taken the easy way out — some would say the logical way out — by declining the first of Robert’s two $20 million options in the six-year, $50 million salary he was given as an electrifying speed-power-defense prospect in 2020. The…

White Sox Give Robert $5 Million Raise After Third 100-Loss Season

ATLANTA, GEORGIA – AUGUST 20: Luis Robert Jr. #88 of the Chicago White Sox looks on during the sixth inning against the Atlanta Braves at Truist Park on August 20, 2025 in Atlanta, Georgia. (Photo by Todd Kirkland/Getty Images)

Getty Images

Talk about playing the long game. The White Sox refuse to give on Luis Robert Jr., both as their center fielder and a potentially valuable asset.

They surprisingly exercised a $20 million option on his contract for 2026 even though he has played only slightly above replacement level since 2023. Health has also been a major issue, with Robert playing 100 games in ’24 and 110 in ’25, when a mid-season resurgence was cut short by a season-ending hamstring strain in late August.

Robert, Andrew Benintendi and Korey Lee are the only members of the 40-man roster left from the start of the 121-loss ordeal two seasons ago. Their high salaries and inconsistent performance have limited their appeal in trades.

Benintendi, who is heading into the fourth season of a five-year, $75 million deal, has raised his production over the last year and a half, delivering an .830 OPS in the second half of ’24 before a second consecutive 20-homer season in ’25.

The Sox would surely trade Benintendi this winter but it hasn’t made sense to cut ties at any point, as the remaining $31 million on his contract is guaranteed. But Robert presents a different situation entirely for a team that has lost 100-plus games three years in a row.

General Manager Chris Getz could have taken the easy way out — some would say the logical way out — by declining the first of Robert’s two $20 million options in the six-year, $50 million salary he was given as an electrifying speed-power-defense prospect in 2020. The cost would have been only a $2 million buyout.

Instead Robert is being given a raise of $5 million from his previous salary.

Hanging onto Robert might seem reasonable if the White Sox were ready to attempt a return to their levels in 2020 and ’21, when they reached the season with a core built around Jose Abreu. That decision would have at least created debate. The one Getz recently announced does little other than raise eyebrows.

It is similar to the decisions Getz made not to take the best offer he could get to trade Roberts at mid-season in ’24 and ’25, amid a full-scale rebuild that saw him and his front-office predecessors deal away Garrett Crochet, Dylan Cease, Lucas Giolito and Michael Kopech, among others.

But Getz simply won’t walk away from a 28-year-old who has accumulated 2.8 rWAR over 210 games the last two seasons, hitting .223 with a .288 on-base percentage, 28 home runs, 56 stolen bases and a .660 OPS.

At least two things must be working in Robert’s favor: the White Sox can certainly afford him (outside of him and Benintendi the current projected 2026 payroll is $27.5 million, per Cot’s Contracts) and he must be good in the clubhouse.

There’s no way manager Will Venable, Getz and chairman Jerry Reinsdorf would have hung onto Robert for so long if he was a poor influence on Miguel Vargas, Colson Montgomery,Kyle Teel, Edgar Quero, Chase Meidroth and the other hitters who are the future of the organization.

Robert won a Gold Glove in 2020 as a rookie and continues to be solid, if not elite, in the field. Statcast’s fielding run value ranked him in the 88th percentile last season. His 90th-percentile sprint speed last season was his best since he was a rookie even though he was twice sidelined by hamstring strains.

None of this means he will still be with the White Sox next season. Robert’s name seems certain to be raised at the winter meetings in December, most likely in complicated multi-player — or even multi-team — deals.

In some scenarios the Sox could take on someone else’s bad contract. In others, the team could significantly pay down Robert’s salary to land a teenaged lottery ticket or two. Maybe they combine some version of both strategies.

There’s a possibility Getz is simply enamored with Robert. Maybe it’s the skeptics who are wrong not to expect him to jump back to his ’23 level, when he was worth 4.9 rWAR.

While Robert finished last season on the Injured List, he had elevated his play. He hit .298 with five home runs and 11 stolen bases in 31 games during the second half. That performance may have played a role in the decision to hang onto him.

Robert would become a valuable trade piece if he earned his way onto the American League All-Star team next July. But who knows? Maybe the Sox would hang onto him for another season.

Robert has another $20 million option for 2027.

Source: https://www.forbes.com/sites/philrogers/2025/11/14/white-sox-give-robert-5-million-raise-after-third-100-loss-season/

Market Opportunity
Whiterock Logo
Whiterock Price(WHITE)
$0.0001306
$0.0001306$0.0001306
-6.71%
USD
Whiterock (WHITE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Buterin unveils Ethereum’s strategy to tackle quantum security challenges ahead. Ethereum focuses on simplifying architecture while boosting security for users. Ethereum’s market stability grows as Buterin’s roadmap gains investor confidence. Ethereum founder Vitalik Buterin has unveiled his long-term vision for the blockchain, focusing on making Ethereum quantum-secure while maintaining its simplicity for users. Buterin presented his roadmap at the Japanese Developer Conference, and splits the future of Ethereum into three phases: short-term, mid-term, and long-term. Buterin’s most ambitious goal for Ethereum is to safeguard the blockchain against the threats posed by quantum computing.  The danger of such future developments is that the future may call into question the cryptographic security of most blockchain systems, and Ethereum will be able to remain ahead thanks to more sophisticated mathematical techniques to ensure the safety and integrity of its protocols. Buterin is committed to ensuring that Ethereum evolves in a way that not only meets today’s security challenges but also prepares for the unknowns of tomorrow. Also Read: Ethereum Giant The Ether Machine Takes Major Step Toward Going Public! However, in spite of such high ambitions, Buterin insisted that Ethereum also needed to simplify its architecture. An important aspect of this vision is to remove unnecessary complexity and make Ethereum more accessible and maintainable without losing its strong security capabilities. Security and simplicity form the core of Buterin’s strategy, as they guarantee that the users of Ethereum experience both security and smooth processes. Focus on Speed and Efficiency in the Short-Term In the short term, Buterin aims to enhance Ethereum’s transaction efficiency, a crucial step toward improving scalability and reducing transaction costs. These advantages are attributed to the fact that, within the mid-term, Ethereum is planning to enhance the speed of transactions in layer-2 networks. According to Butterin, this is part of Ethereum’s expansion, particularly because there is still more need to use blockchain technology to date. The other important aspect of Ethereum’s development is the layer-2 solutions. Buterin supports an approach in which the layer-2 networks are dependent on layer-1 to perform some essential tasks like data security, proof, and censorship resistance. This will enable the layer-2 systems of Ethereum to be concerned with verifying and sequencing transactions, which will improve the overall speed and efficiency of the network. Ethereum’s Market Stability Reflects Confidence in Long-Term Strategy Ethereum’s market performance has remained solid, with the cryptocurrency holding steady above $4,000. Currently priced at $4,492.15, Ethereum has experienced a slight 0.93% increase over the last 24 hours, while its trading volume surged by 8.72%, reaching $34.14 billion. These figures point to growing investor confidence in Ethereum’s long-term vision. The crypto community remains optimistic about Ethereum’s future, with many predicting the price could rise to $5,500 by mid-October. Buterin’s clear, forward-thinking strategy continues to build trust in Ethereum as one of the most secure and scalable blockchain platforms in the market. Also Read: Whales Dump 200 Million XRP in Just 2 Weeks – Is XRP’s Price on the Verge of Collapse? The post Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! appeared first on 36Crypto.
Share
Coinstats2025/09/18 01:22
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26